CD73 (ecto-5'-nucleotidase) hepatocyte levels differ across mouse strains and contribute to mallory-denk body formation

Hepatology

Volumn 58, Issue 5, 2013, Pages 1790-1800

  Snider, Natasha T ^a   Griggs, Nicholas W ^a   Singla, Amika ^a   Moons, David S ^a   Weerasinghe, Sujith V W ^a   Lok, Anna S ^a   Ruan, Chunhai ^a   Burant, Charles F ^a   Conjeevaram, Hari S ^a   Omary, M Bishr ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ECTO 5' NUCLEOTIDASE; K 18; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVITY; ENZYME HISTOCHEMISTRY; HEPATOMEGALY; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IN VIVO STUDY; LIVER BIOPSY; LIVER CELL; LIVER INJURY; MALLORY DENK BODY; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURINE METABOLISM;

5'-NUCLEOTIDASE; ANIMALS; HEPATOCYTES; HUMANS; MALLORY BODIES; METABOLOMICS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; PURINES; SPECIES SPECIFICITY;

EID: 84887019099     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26525     Document Type: Article

References (31)

1. Zatloukal K, French SW, Stumptner C, Strnad P, Harada M, Toivola DM, et al. From Mallory to Mallory-Denk bodies: what, how, and why? Exp Cell Res 2007;313:2033-2049.
2. Zatloukal K, Fesus L, Denk H, Tarcsa E, Spurej G, Bock G. High amount of epsilon-(gamma-glutamyl)lysine cross-links in Mallory bodies. Lab Invest 1992;66:774-777.
3. Strnad P, Harada M, Siegel M, Terkeltaub RA, Graham RM, Khosla C, Omary MB. Transglutaminase 2 regulates mallory body inclusion formation and injury-associated liver enlargement. Gastroenterology 2007;132:1515-1526.
4. Lackner C, Gogg-Kamerer M, Zatloukal K, Stumptner C, Brunt EM, Denk H. Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis. J Hepatol 2008;48:821-828.
5. Kleiner DE, Brunt EM. Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research. Semin Liver Dis 2012;32:3-13.
6. Cortez-Pinto H, Baptista A, Camilo ME, De Moura MC. Nonalcoholic steatohepatitis-a long-term follow-up study: comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Dig Dis Sci 2003;48:1909-1913.
7. Gramlich T, Kleiner DE, McCullough AJ, Matteoni CA, Boparai N, Younossi ZM. Pathologic features associated with fibrosis in nonalcoholic fatty liver disease. Hum Pathol 2004;35:196-199.
8. Molnar A, Haybaeck J, Lackner C, Strnad P. The cytoskeleton in nonalcoholic steatohepatitis: 100 years old but still youthful. Expert Rev Gastroenterol Hepatol 2011;5:167-177.
9. Gerber MA, Orr W, Denk H, Schaffner F, Popper H. Hepatocellular hyalin in cholestasis and cirrhosis: its diagnostic significance. Gastroenterology 1973;64:89-98.
10. Fleming KA, McGee JO. Alcohol induced liver disease. J Clin Pathol 1984;37:721-733.
11. Rakoski MO, Brown MB, Fontana RJ, Bonkovsky HL, Brunt EM, Goodman ZD, et al. Mallory-Denk bodies are associated with outcomes and histologic features in patients with chronic hepatitis C. Clin Gastroenterol Hepatol 2011;9:902-909.e1.
12. Hanada S, Strnad P, Brunt EM, Omary MB. The genetic background modulates susceptibility to mouse liver Mallory-Denk body formation and liver injury. Hepatology 2008;48:943-952.
13. Omary MB, Ku NO, Strnad P, Hanada S. Toward unraveling the complexity of simple epithelial keratins in human disease. J Clin Invest 2009;119:1794-1805.
14. Strnad P, Zatloukal K, Stumptner C, Kulaksiz H, Denk H. Mallory-Denk-bodies: lessons from keratin-containing hepatic inclusion bodies. Biochim Biophys Acta 2008;1782:764-774.
15. Snider NT, Weerasinghe SV, Singla A, Leonard JM, Hanada S, Andrews PC, et al. Energy determinants GAPDH and NDPK act as genetic modifiers for hepatocyte inclusion formation. J Cell Biol 2011;195:217-229.
16. Colgan SP, Eltzschig HK, Eckle T, Thompson LF. Physiological roles for ecto-5'-nucleotidase (CD73). Purinergic Signal 2006;2:351-360.
17. Resta R, Yamashita Y, Thompson LF. Ecto-enzyme and signaling functions of lymphocyte CD73. Immunol Rev 1998;161:95-109.
18. Peng Z, Borea PA, Varani K, Wilder T, Yee H, Chiriboga L, et al. Adenosine signaling contributes to ethanol-induced fatty liver in mice. J Clin Invest 2009;119:582-594.
19. Peng Z, Fernandez P, Wilder T, Yee H, Chiriboga L, Chan ES, Cronstein BN. Ecto-5'-nucleotidase (CD73)-mediated extracellular adenosine production plays a critical role in hepatic fibrosis. FASEB J 2008;22:2263-2272.
20. Ku NO, Michie S, Oshima RG, Omary MB. Chronic hepatitis, hepatocyte fragility, and increased soluble phosphoglycokeratins in transgenic mice expressing a keratin 18 conserved arginine mutant. J Cell Biol 1995;131:1303-1314.
21. Thompson LF, Eltzschig HK, Ibla JC, Van De Wiele CJ, Resta R, Morote-Garcia JC, Colgan SP. Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia. J Exp Med 2004;200:1395-1405.
22. Frederiks WM, Marx F. A quantitative histochemical study of 5'-nucleotidase activity in rat liver using the lead salt method and polyvinyl alcohol. Histochem J 1988;20:207-214.
23. Bieche I, Asselah T, Laurendeau I, Vidaud D, Degot C, Paradis V, et al. Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection. Virology 2005;332:130-144.
24. Greco D, Kotronen A, Westerbacka J, Puig O, Arkkila P, Kiviluoto T, et al. Gene expression in human NAFLD. Am J Physiol Gastrointest Liver Physiol 2008;294:G1281-G1287.
25. Knapp K, Zebisch M, Pippel J, El-Tayeb A, Muller CE, Strater N. Crystal structure of the human ecto-5'-nucleotidase (CD73): insights into the regulation of purinergic signaling. Structure 2012;20:2161-2173.
26. Hanada S, Snider NT, Brunt EM, Hollenberg PF, Omary MB. Gender dimorphic formation of mouse Mallory-Denk bodies and the role of xenobiotic metabolism and oxidative stress. Gastroenterology 2010;138:1607-1617.
27. Ohta A, Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 2001;414:916-920.
28. Fausther M, Sheung N, Saiman Y, Bansal MB, Dranoff JA. Activated hepatic stellate cells upregulate transcription of ecto-5'-nucleotidase/CD73 via specific SP1 and SMAD promoter elements. Am J Physiol Gastrointest Liver Physiol 2012;303:G904-G914.
29. Matsuura S, Eto S, Kato K, Tashiro Y. Ferritin immunoelectron microscopic localization of 5'-nucleotidase on rat liver cell surface. J Cell Biol 1984;99:166-173.
30. Stanley KK, Edwards MR, Luzio JP. Subcellular distribution and movement of 5'-nucleotidase in rat cells. Biochem J 1980;186:59-69.
31. Maguire GA, Luzio JP. The presence and orientation of ecto-5'-nucleotidase in rat liver lysosomes. FEBS Lett 1985;180:122-126.